Image

North America Molecular Diagnostics Services Market – Industry Trends and Forecast to 2030

Healthcare

Image

North America Molecular Diagnostics Services Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Published Report
  • Nov 2022
  • North America
  • 350 Pages
  • No of Tables: 107
  • No of Figures: 31

North America Molecular Diagnostics Services Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 56,705.30 USD Thousand
Diagram Market Size (Forecast Year) USD 103,058.75 USD Thousand
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

North America Molecular Diagnostics Services Market, By Service Type (Instrument Repair Services, Training Services, Compliance Services, Calibration Services, Maintenance Services, Scalable Automation Services, Turnkey Services, Instrument Relocation Services, Hardware Customization, Performance Assurance Services, Design and Development Services, Supply Chain Solutions, New Product Introduction Services, Manufacturing Services, Environmental & Regulatory Services, Medical Management Systems Certification & Auditing, Clinical Research Services, Consultative Services, and Other Services), Technology (PCR, Real Time PCR, Next Generation Sequencing, and Other Technologies), End User (Hospitals, Diagnostic Centers, Academic & Research Institutions, and Others) Industry Trends and Forecast to 2030.

North America Molecular Diagnostics Services Market

North America Molecular Diagnostics Services Market Analysis and Insights 

The increasing demand for testing, therapies, and faster diagnosis is helping to boost overall market growth. The growing funding in the molecular diagnostics sector is also attributing to the market growth. The major market players are highly focused on various new diagnostics services. In addition, the rising prevalence of chronic and infectious diseases is also contributing to the rising demand for the market.

North America Molecular Diagnostics Services Market

North America Molecular Diagnostics Services Market

The North America molecular diagnostics services market is growing in the forecast year due to the rise in market players and the availability of various advanced molecular diagnostics services in the market. Along with this, the number of government and private collaborations has increased in the market which is further boosting the market growth. However, the high cost associated with molecular diagnostics labs setups and other instrumentations might hamper the market growth in the forecast period.

The strategic initiatives by key market players, rising government and private collaborations, and increasing R&D activities are giving opportunities for market growth. However, stringent regulations by the government and lack of skilled professionals are the key challenges to market growth.

North America molecular diagnostics services market is expected to reach USD 103,058.75 thousand by 2030 from USD 56,705.30 thousand in 2022, growing at a CAGR of 8.0% in the forecast period of 2023 to 2030.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Year

2021 (Customizable to 2020 - 2016)

Quantitative Units

Revenue in USD Thousand

Segments Covered

By Service Type (Instrument Repair Services, Training Services, Compliance Services, Calibration Services, Maintenance Services, Scalable Automation Services, Turnkey Services, Instrument Relocation Services, Hardware Customization, Performance Assurance Services, Design and Development Services, Supply Chain Solutions, New Product Introduction Services, Manufacturing Services, Environmental & Regulatory Services, Medical Management Systems Certification & Auditing, Clinical Research Services, Consultative Services, and Other Services), Technology (PCR, Real Time PCR, Next Generation Sequencing, and Other Technologies), End User (Hospitals, Diagnostic Centers, Academic & Research Institutions, and Others.

Countries Covered

U.S., Canada, and Mexico

Market Players Covered

F. Hoffmann-La Roche Ltd, Danaher, BIOMERIEUX, QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, Abbott, DiaSorin S.p.A., and Hologic, Inc among others

Market Definition

Molecular diagnostics is known as the process of identifying a disease by studying molecules such as proteins, DNA, and RNA in a tissue or fluid. These molecular diagnostics services are used as a strategy to research, analyze, and diagnose certain molecules with the help of technologies in the laboratory. These are specially used for the measurement of a specific biomarker in the fluids, Polymerase Chain Reaction (PCR)-based detection of bacterial genes, and molecular responses of any certain infection. These services are used to provide more efficient testing and diagnostics.

Molecular diagnostic services enable researchers and technicians to efficiently and effectively produce output in less time, which drives the Asia-Pacific molecular diagnostics services market. Furthermore, with the potential for clinical practice, these services are used to give additional support to boost efficiency in molecular diagnosis and the presence of major market players also contributes to the market growth.

North America Molecular Diagnostics Services Market Dynamics

Drivers

  • Rising prevalence of chronic and infectious diseases

Chronic and infectious diseases are currently the major cause of death among adults in almost all countries. The prevalence of chronic and infectious diseases is increasing, as a result of which people are more dependent on diagnostic labs and centers for disease diagnosis. The rising prevalence has increased the demand for molecular diagnostics services to provide accurate diagnoses, therapies, and test results within less time. Health-damaging behaviors- particularly tobacco use, lack of physical activity, poor eating habits, and excessive alcohol use are major contributors to the rising prevalence of chronic and infectious diseases. These diseases can be diagnosed by several techniques such as immunoassay, molecular techniques, PCR, and gene manipulation techniques among others. Hence, the demand for molecular diagnostic services is increasing to fulfill the patient’s demand for faster diagnosis and treatment.

The occurrence of chronic and infectious diseases is high and the number of molecular tests has also increased for diagnosis and treatment, the demand for products and services will rise eventually. Hence, the rising prevalence of chronic and infectious diseases is driving market growth across the globe.

  • Increasing demand for testing, therapies, faster diagnostics

The demand for high-priced specialist therapies is more in the present scenario. The awareness among consumers about faster diagnostics is rising and the adoption of analyzer software for molecular diagnostics is increasing at a higher rate. Molecular diagnostics render accurate and effective results and have indispensable applications in disease diagnostics. People are preferring personalized medications that rely on identifying the genetic, epigenomic, and clinical information of the individual.

Furthermore, in recent years patients are shifting to personalized care and treatment and the demand for molecular testing, therapies, and faster diagnostics is increasing which may act as a driving factor for market growth across the globe.

  • Growing funding in the molecular diagnostics segment

Government initiatives, schemes, and funding activities to support and promote innovation and development have increased, as a result, the molecular diagnostics segment is growing rapidly. This segment is an integral part of disease control, hence the funding is rising and scientists are more focused on developing new ideas for disease control and healthy survival. Again chronic disease like cancer has become dominant all over the world and the demand for specialized treatment and the fastest diagnosis is rising.

As the government and public funding are rising to support the molecular diagnostic segment for better innovations and alternatives for faster diagnosis, the market is boosting to a higher extent. Considering the above instances, it can be predicted that growing funding in the molecular diagnostics segment is going to drive the market in near future.

Opportunity

  • Increasing research & development activities

The increasing R&D activities offer alternative options for receiving molecular diagnostics services globally, improving access and reducing costs associated with diagnostics services. However, the full potential of molecular diagnostics has not been realized with slow and fragmented uptake.

The increase in the awareness program, rising awareness initiatives, and support through the government have increased the usage of molecular diagnostics in various areas. The increased R&D activities will help to increase the knowledge to develop new or improved products and processes. The design, technical manufacturing, and phase trials are often the most important part of R&D activities that provide improvement in the services.

As the market players are constantly engaged in R&D activities more molecular diagnostic services are likely to be involved in the market. This would increase the demand for molecular diagnostic services by various end users such as hospitals, clinics, and diagnostic centers.

Restraint/Challenge

  • High cost associated with molecular diagnostics labs setups and other instrumentations

The molecular diagnostic lab comprises several techniques such as Fluorescence In Situ Hybridization (FISH), Polymerase Chain Reaction (PCR)-based molecular diagnostics, interphase chromosome profiling, DNA fingerprinting, and others. There are several services associated with a molecular diagnostics lab such as installation service, validation service, rectification service, automation services, and others. Hence, the overall lab setup and instrumentation costs are too high which becomes quite difficult to be established without government and private funding and investments and this may restrain the market growth.

Post-COVID-19 Impact on North America Molecular Diagnostics Services Market

The post-COVID-19 has positively affected the market. A large number of the population were affected by this pandemic and the number of diagnostics tests had increased worldwide. Mostly, the PCR-based COVID-19 diagnosis increased. Thus, COVID-19 affected the market positively.

Recent Development

  • In August 2022, Abbott shared its new study on a blood test for a concussion that can predict outcomes from brain injury and inform treatment interventions. This has helped the company to increase its North America presence in the market.

North America Molecular Diagnostics Services Market Scope

North America molecular diagnostics services market is segmented into three notable segments based on service type, technology, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

By Service Type

  • Instrument Repair Services
  • Training Services
  • Maintenance Services
  • Calibration Services
  • Compliance Services
  • Turnkey Services
  • Scalable Automation Services
  • Hardware Customization
  • Instrument Relocation Services
  • Performance Assurance Services
  • Design & Development Services
  • Supply Chain Solutions
  • New Product Introduction Services
  • Manufacturing Services
  • Environmental & Regulatory Services
  • Medical Management Systems Certification & Auditing
  • Clinical Research Services
  • Consultative Services
  • Other Services

Based on service type, the market is segmented into instrument repair services, training services, maintenance services, calibration services, compliance services, turnkey services, scalable automation services, hardware customization, instrument relocation services, performance assurance services, design & development services, supply chain solutions, new product introduction services, manufacturing services, environmental & regulatory services, medical management systems certification & auditing, clinical research services, consultative services, and other services.

By Technology

  • PCR
  • Real Time PCR
  • Next Generation Sequencing
  • Other Technologies

Based on technology, the market is segmented into PCR, real time PCR, next generation sequencing, and other technologies.

By End User

  • Hospitals
  • Diagnostics Centers
  • Academic & Research Institutes
  • Others

Molecular Diagnostics Services Market

Based on end user, the market is segmented into hospitals, diagnostic centers, academic & research institutes, and others.

North America Molecular Diagnostics Services Market Regional Analysis/Insights   

The North America molecular diagnostics services market is analyzed and market size insights and trends are provided by country, service type, technology, and end user.

The countries covered in this report are U.S., Canada, and Mexico.

The U.S. dominates the North America molecular diagnostics services market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period.

This is due to implementing awareness programs among people and the rise in technological advancement further improves this market growth.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of North America brands and the challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Molecular Diagnostics Services Market Share Analysis

The North America molecular diagnostics services market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the market.

Some of the major players operating in the North America molecular diagnostics services market are F. Hoffmann-La Roche Ltd, Danaher, BIOMERIEUX, QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, Abbott, DiaSorin S.p.A., and Hologic, Inc among others.


SKU-

TABLE 1 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 1 NORTH AMERICA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 2 NORTH AMERICA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 3 NORTH AMERICA MAINTENANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 4 NORTH AMERICA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 5 NORTH AMERICA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 6 NORTH AMERICA CALIBRATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 7 NORTH AMERICA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 8 NORTH AMERICA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 9 NORTH AMERICA TURNKEY SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 10 NORTH AMERICA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 11 NORTH AMERICA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 12 NORTH AMERICA HARDWARE CUSTOMIZATION IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 13 NORTH AMERICA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 14 NORTH AMERICA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 15 NORTH AMERICA PERFORMANCE ASSURANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 16 NORTH AMERICA DESIGN AND DEVELOPMENT SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 17 NORTH AMERICA SUPPLY CHAIN SOLUTIONS SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 18 NORTH AMERICA NEW PRODUCT INTRODUCTION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 19 NORTH AMERICA MANUFACTURING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 20 NORTH AMERICA ENVIRONMENTAL AND REGULATORY SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 21 NORTH AMERICA MEDICAL MANAGEMENT SYSTEMS AND AUDITING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 22 NORTH AMERICA CLINICAL RESEARCH SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 23 NORTH AMERICA CONSULTATIVE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 24 NORTH AMERICA OTHER SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 25 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 26 NORTH AMERICA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 27 NORTH AMERICA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 28 NORTH AMERICA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 29 NORTH AMERICA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 30 NORTH AMERICA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 31 NORTH AMERICA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 32 NORTH AMERICA OTHER TECHNOLOGIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 33 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 34 NORTH AMERICA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 35 NORTH AMERICA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 36 NORTH AMERICA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 37 NORTH AMERICA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 38 NORTH AMERICA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 39 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 40 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 41 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 42 NORTH AMERICA OTHERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 43 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 44 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 45 NORTH AMERICA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 46 NORTH AMERICA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 47 NORTH AMERICA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 48 NORTH AMERICA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 49 NORTH AMERICA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 50 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 51 NORTH AMERICA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 52 NORTH AMERICA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 53 NORTH AMERICA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 54 NORTH AMERICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 55 NORTH AMERICA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE 2021-2030 (USD THOUSAND)

TABLE 56 NORTH AMERICA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 57 NORTH AMERICA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 58 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 59 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 60 U.S. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 61 U.S. INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 62 U.S. TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 63 U.S. COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 64 U.S. SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 65 U.S. INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 66 U.S. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 67 U.S. REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 68 U.S. PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 69 U.S. NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 70 U.S. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 71 U.S. HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE 2021-2030 (USD THOUSAND)

TABLE 72 U.S. DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 73 U.S. CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 74 U.S. AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 75 U.S. ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 76 CANADA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 77 CANADA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 78 CANADA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 79 CANADA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 80 CANADA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 81 CANADA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 82 CANADA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 83 CANADA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 84 CANADA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 85 CANADA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 86 CANADA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 87 CANADA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE 2021-2030 (USD THOUSAND)

TABLE 88 CANADA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 89 CANADA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 90 CANADA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 91 CANADA ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 92 MEXICO MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 93 MEXICO INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 94 MEXICO TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 95 MEXICO COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 96 MEXICO SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 97 MEXICO INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 98 MEXICO MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)

TABLE 99 MEXICO REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 100 MEXICO PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 101 MEXICO NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 102 MEXICO MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 103 MEXICO HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE 2021-2030 (USD THOUSAND)

TABLE 104 MEXICO DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 105 MEXICO CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 106 MEXICO AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

TABLE 107 MEXICO ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The North America Molecular Diagnostics Services Market is projected to grow at a CAGR of 8.0% during the forecast period by 2030.
The future market value of the North America Molecular Diagnostics Services Market is expected to reach USD 103,058.75 thousand by 2030.
The major players in the North America Molecular Diagnostics Services Market are F. Hoffmann-La Roche Ltd, Danaher, BIOMERIEUX, QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, Abbott, DiaSorin S.p.A., and Hologic, Inc among others.
The countries covered in the North America Molecular Diagnostics Services Market are U.S., Canada, and Mexico.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials